Resveratrol induces catalytic bioscavenger paraoxonase 1 expression and protects against chemical warfare nerve agent toxicity in human cell lines

被引:23
作者
Curtin, Bryan F. [1 ]
Seetharam, Karthik I. [1 ]
Dhoieam, Pilin [1 ]
Gordon, Richard K. [1 ]
Doctor, Bhupendra P. [1 ]
Nambiar, Madhusoodana P. [1 ,2 ]
机构
[1] Walter Reed Army Inst Res, Dept Biochem Pharmacol, Div Biochem, Silver Spring, MD 20910 USA
[2] USUHS, Dept Med, Bethesda, MD USA
关键词
nerve agents; organophosphates; transcriptional inducers; paraoxonase gene expression; neuroprotection;
D O I
10.1002/jcb.21543
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Current advances in enzyme bioscavenger prophylactic therapy against chemical warfare nerve agent (CWNA) exposure are moving towards the identification of catalytic bioscavengers that can degrade large doses of organophosphate (OP) nerve agents without self destruction. This is a preferred method compared to therapy with the purified stoichiometric bioscavenger, butyrylcholinesterase, which binds OPs 1:1 and would thus require larger doses for treatment. Paraoxonase-1 (PON-1) is one such catalytic bioscavenger that has been shown to hydrolyze OP insecticides and contribute to detoxification in animals and humans. Here we investigated the effects of a common red wine ingredient, Resveratrol (RSV), to induce the expression of PON-1 in the human hepatic cell line HC04 and evaluated the protection against CWNA simulants. Dose-response curves showed that a concentration of 20 mu M RSV was optimal in inducing PON-1 expression in HC04 cells. RSV at 20 mu M increased the extracellular PON-1 activity approximately 150% without significantly affecting the cells. Higher doses of RSV were cytotoxic to the cells. Resveratrol also induced PON-1 in the human lung cell line A549. RSV pre-treatment significantly (P= 0.05) protected the hepatic cells against exposure to 2 x LD50 of soman and sarin simulants. However, lung cells were protected against soman simulant exposure but not against sarin simulant exposure following RSV treatment. In conclusion, these studies indicate that dietary inducers, such as RSV, can up-regulate PON-1, a catalytic bioscavenger, which can then hydrolyze and protect against CWNA-induced toxicity, providing a prospective new method to protect against CWNA exposure.
引用
收藏
页码:1524 / 1535
页数:12
相关论文
共 45 条
[1]  
ADKINS S, 1993, AM J HUM GENET, V52, P598
[2]  
Aviram M, 1999, Harefuah, V136, P620
[3]   Biochemical and behavioral effects of soman vapors in low concentrations [J].
Bajgar, J ;
Sevelová, L ;
Krejcová, G ;
Fusek, J ;
Vachek, J ;
Kassa, J ;
Herink, J ;
de Jong, LPA ;
Benschop, HP .
INHALATION TOXICOLOGY, 2004, 16 (08) :497-507
[4]   Smoking is associated with reduced serum levels of the antioxidant enzyme, paraoxonase, in Type 2 diabetic patients [J].
Boemi, M ;
Sirolla, C ;
Testa, R ;
Cenerelli, S ;
Fumelli, P ;
James, RW .
DIABETIC MEDICINE, 2004, 21 (05) :423-427
[5]   Genetic variation in paraoxonase-1 and paraoxonase-2 is associated with variation in plasma lipoproteins in Alberta Hutterites [J].
Boright, AP ;
Connelly, PW ;
Brunt, JH ;
Scherer, SW ;
Tsui, LC ;
Hegele, RA .
ATHEROSCLEROSIS, 1998, 139 (01) :131-136
[6]   Expression of human paraoxonase (PON1) during development [J].
Cole, TB ;
Jampsa, RL ;
Walter, BJ ;
Arndt, TL ;
Richter, RJ ;
Shih, DM ;
Tward, A ;
Lusis, AJ ;
Jack, RM ;
Costa, LG ;
Furlong, CE .
PHARMACOGENETICS, 2003, 13 (06) :357-364
[7]   Modulation of paraoxonase (PON1) activity [J].
Costa, LG ;
Vitalone, A ;
Cole, TB ;
Furlong, CE .
BIOCHEMICAL PHARMACOLOGY, 2005, 69 (04) :541-550
[8]   Polymorphisms of paraoxonase (PON1) and their significance in clinical toxicology of organophosphates [J].
Costa, LG ;
Cole, TB ;
Furlong, CE .
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 2003, 41 (01) :37-45
[9]   Measurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity [J].
Costa, LG ;
Cole, TB ;
Vitalone, A ;
Furlong, CE .
CLINICA CHIMICA ACTA, 2005, 352 (1-2) :37-47
[10]   Paraoxonas (PON1) as a biomarker of susceptibility for organophosphate toxicity [J].
Costa, LG ;
Richter, RJ ;
Li, WF ;
Cole, T ;
Guizzetti, M ;
Furlong, CE .
BIOMARKERS, 2003, 8 (01) :1-12